Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

26 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CLDX.OQ


Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127. CDX-110, is an immunotherapeutic... (more)


Beta: 2.83
Market Cap (Mil.): $1,840.16
Shares Outstanding (Mil.): 89.59
Dividend: --
Yield (%): --


  CLDX.OQ Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -1.23 -- --
ROI: -52.30 -2.35 17.27
ROE: -54.69 -3.55 18.18
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Zacks Investment Research Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks